Murine BAFF expression is up-regulated by estrogen and interferons: Implications for sex bias in the development of autoimmunity

Molecular Immunology

Volumn 53, Issue 1-2, 2013, Pages 15-23

  Panchanathan, Ravichandran ^a,b   Choubey, Divaker ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BAFF; Estrogen; Interferon; P202; SLE

Indexed keywords

ALPHA INTERFERON; B CELL ACTIVATING FACTOR; CD11B ANTIGEN; CD19 ANTIGEN; ESTROGEN RECEPTOR ALPHA; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 5; MESSENGER RNA; STAT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL ISOLATION; CELL LINE; CONTROLLED STUDY; FEMALE; GENDER; IMMUNOCOMPETENT CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX; SPLEEN; STEADY STATE; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; ESTROGENS; FEMALE; IMMUNOBLOTTING; INTERFERONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; UP-REGULATION;

MURINAE; MUS;

EID: 84863509590     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.06.013     Document Type: Article

References (51)

1. Amezcua Vesely M.C., Schwartz M., Bermejo D.A., Montes C.L., Cautivo K.M., Kalergis A.M., et al. FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. Journal of Immunology 2012, (Epub ahead of print).
2. Becker-Merok A., Nikolaisen C., Nossent H.C. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels: disease measures and time. Lupus 2006, 15(9):570-576.
3. Boross P., Arandhara V.L., Martin-Ramirez J., Santiago-Raber M.L., Carlucci F., Flierman R., et al. The inhibiting Fc receptor for IgG: FcγRIIB, is a modifier of autoimmune susceptibility. Journal of Immunology 2011, 187(3):1304-1313.
4. 1 mice. Genes and Immunity 2008, 9(2):137-152.
5. Choubey D., Kotzin B.L. Interferon-inducible p202 in the susceptibility to systemic lupus. Frontiers in Bioscience 2002, 7:e252-e262.
6. Choubey D., Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunology Letters 2008, 119(1-2):32-41.
7. Choubey D., Panchanathan R., Duan X., Liu H., Liu H. Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. Journal of Interferon and Cytokine Research 2011, 31(12):893-906.
8. Choubey D., Panchanathan R., Liu H. Comment on " The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility" Journal of Immunology 2011, 187(8):3909.
9. Cohen-Solal J.F., Jeganathan V., Hill L., Kawabata D., Rodriguez-Pinto D., Grimaldi C., et al. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 2008, 17(6):528-532.
10. Gribaudo G., Toniato E., Engel D.A., Lengyel P. Interferons as gene activators. Characteristics of an interferon-activatable enhancer. Journal of Biological Chemistry 1987, 262(24):11878-11883.
11. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. Journal of Clinical Investigation 2002, 109(1):59-68.
12. Gubbels M.R., Jørgensen T.N., Metzger T.E., Menze K., Steele H., Flannery S.A., et al. Effects of MHC and gender on lupus-like autoimmunity in Nba2 congenic mice. Journal of Immunology 2005, 175(9):6190-6196.
13. Harigai M., Kawamoto M., Hara M., Kubota T., Kamatani N., Miyasaka N. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. Journal of Immunology 2008, 181(3):2211-2219.
14. Ittah M., Miceli-Richard C., Eric Gottenberg J., Lavie F., Lazure T., Ba N., et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Research and Therapy 2006, 8(2):R51.
15. Jørgensen T.N., Roper E., Thurman J.M., Marrack P., Kotzin B.L. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2×NZW)F(1) mice. Genes Immun 2007, 8(8):653-662.
16. Jørgensen T.N., Alfaro J., Enriquez H.L., Jiang C., Loo W.M., Atencio S., et al. Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus. Journal of Immunology 2010, 184(2):775-786.
17. Kato A., Truong-Tran A.Q., Scott A.L., Matsumoto K., Schleimer R.P. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-β-dependent mechanism. Journal of Immunology 2006, 177(10):7164-7172.
18. Kim H.A., Jeon S.H., Seo G.Y., Park J.B., Kim P.H. TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways. Journal of Leukocyte Biology 2008, 83(6):1431-1439.
19. Kim H.A., Seo G.Y., Kim P.H. Macrophage-derived BAFF induces AID expression through the p38MAPK/CREB and JNK/AP-1 pathways. Journal of Leukocyte Biology 2011, 89(3):393-398.
20. Kotzin B.L. Systemic lupus erythematosus. Cell 1996, 85(3):303-306.
21. Krumbholz M., Faber H., Steinmeyer F., Hoffmann L.A., Kümpfel T., Pellkofer H., et al. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity. Brain 2008, 131(Pt 6):1455-1463.
22. Liu Z., Bethunaickan R., Huang W., Ramanujam M., Madaio M.P., Davidson A. IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. Journal of Immunology 2011, 187(3):1506-1513.
23. Mackay F., Schneider P. Cracking the BAFF code. Nature Reviews. Immunology 2009, 9(7):491-502.
24. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. Journal of Experimental Medicine 1999, 190(11):1697-1710.
25. Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annual Review of Immunology 2003, 21:231-264.
26. Manzi S., Sánchez-Guerrero J., Merrill J.T., Furie R., Gladman D., Navarra S.V., et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Annals of the Rheumatic Diseases 2012, (Epub ahead of print).
27. Mohan C. Murine lupus genetics: lessons learned. Current Opinion in Rheumatology 2001, 13(5):352-360.
28. Moon E.Y., Park H. B cell activating factor (BAFF) gene promoter activity depends upon co-activator: p300. Immunobiology 2007, 212(8):637-645.
29. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999, 285(5425):260-263.
30. Ohata J., Zvaifler N.J., Nishio M., Boyle D.L., Kalled S.L., Carson D.A., et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. Journal of Immunology 2005, 174(2):864-870.
31. Panchanathan R., Shen H., Bupp M.G., Gould K.A., Choubey D. Female and male sex hormones differentially regulate expression of Ifi202: an interferon-inducible lupus susceptibility gene within the Nba2 interval. Journal of Immunology 2009, 183(11):7031-7038.
32. Panchanathan R., Shen H., Zhang X., Ho S.M., Choubey D. Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One 2010, 5(5):e10868.
33. Panchanathan R., Duan X., Shen H., Rathinam V.A., Erickson L.D., Fitzgerald K.A., et al. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202: a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. Journal of Immunology 2010, 185(12):7385-7393.
34. Panchanathan R., Shen H., Duan X., Rathinam V.A., Erickson L.D., Fitzgerald K.A., et al. Aim2-deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202: a lupus susceptibility protein. Journal of Immunology 2011, 186(12):6762-6770.
35. Panchanathan R., Duan X., Arumugam M., Shen H., Liu H., Choubey D. Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Molecular Immunology 2011, 49(1-2):273-280.
36. Panchanathan R., Liu H., Liu H., Fang C.M., Erickson L.D., Pitha P.M., et al. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. Journal of Immunology 2012, 188(1):270-278.
37. Pauklin S., Sernández I.V., Bachmann G., Ramiro A.R., Petersen-Mahrt S.K. Estrogen directly activates AID transcription and function. Journal of Experimental Medicine 2009, 206(1):99-111.
38. Pennell L.M., Galligan C.L., Fish E.N. Sex affects immunity. Journal of Autoimmunity 2012, 38(2-3):J282-J291.
39. Pramanik R., Jørgensen T.N., Xin H., Kotzin B.L., Choubey D. Interleukin-6 induces expression of Ifi202: an interferon-inducible candidate gene for lupus susceptibility. Journal of Biological Chemistry 2004, 279(16):16121-16127.
40. Rickert R.C., Jellusova J., Miletic A.V. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunological Reviews 2011, 244(1):115-133.
41. Rozzo S.J., Allard J.D., Choubey D., Vyse T.J., Izui S., Peltz G., et al. Evidence for an interferon-inducible gene: Ifi202, in the susceptibility to systemic lupus. Immunity 2001, 15(3):435-443.
42. Salloum R., Niewold T.B. Interferon regulatory factors in human lupus pathogenesis. Translational Research 2011, 157(6):326-331.
43. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001, 293(5537):2111-2114.
44. Theofilopoulos A.N., Dixon F.J. Murine models of systemic lupus erythematosus. Advances in Immunology 1985, 37:269-290.
45. Theofilopoulos A.N., Balderas R.S., Shawler D.L., Lee S., Dixon F.J. Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. Journal of Experimental Medicine 1981, 153(6):1405-1414.
46. Tsokos G.C. Systemic lupus erythematosus. New England Journal of Medicine 2011, 365(22):2110-2121.
47. Venkatesh J., Yoshifuji H., Kawabata D., Chinnasamy P., Stanevsky A., Grimaldi C.M., et al. Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation. Journal of Immunology 2011, 186(9):5304-5312.
48. Whitacre C.C. Sex differences in autoimmune disease. Nature Immunology 2001, 2(9):777-780.
49. Yamada T., Lizhong S., Takahashi N., Kubo S., Narita N., Suzuki D., et al. Poly(I:C) induces BLyS-expression of airway fibroblasts through phosphatidylinositol 3-kinase. Cytokine 2010, 50(2):163-169.
50. Yamauchi M., Hashimoto M., Ichiyama K., Yoshida R., Hanada T., Muta T., Komune S., Kobayashi T., Yoshimura A. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice: is a positive regulator for NF-kappaB activation in dendritic cells. International Immunology 2007, 19(8):935-942.
51. Yoshimoto K., Tanaka M., Kojima M., Setoyama Y., Kameda H., Suzuki K., et al. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome. Arthritis Research and Therapy 2011, 13(5):R170.